A carregar...
Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials
BACKGROUND: Huntington's disease (HD) develops in individuals with extended cytosine‐adenine‐guanine (CAG) repeats within the huntingtin (HTT) gene, causing neurodegeneration and progressive motor and cognitive symptoms. The inclusion of mutant HTT carriers in whom overt symptoms are not yet fu...
Na minha lista:
| Publicado no: | Mov Disord |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7818458/ https://ncbi.nlm.nih.gov/pubmed/32686867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.28222 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|